Dr. Stephen Hauser was a young resident at Harvard when he met his first patient with multiple sclerosis, a woman with a thriving professional life who’d been completely wiped out by her condition, ...

What Is Cognitive Rehabilitation for nrSPMS? Nonrelapsing secondary progressive multiple sclerosis (nrSPMS) comes with many challenges. One of the biggest can be its impact on your cognition, which ...

There is no increased relapse risk in patients with multiple sclerosis (MS) and comorbid cancer who are receiving immune checkpoint inhibitor (ICI) therapy, results of a small study suggest. MS ...

Roche (RHHBF) (RHHBY) has announced plans to seek regulatory review for an experimental therapy for multiple sclerosis, an autoimmune condition affecting the central nervous system, even as its ...

A study recently published in the BMJ’s Journal of Neurology, Neurosurgery, and Psychiatry found that a digital interactive therapy tool designed for multiple sclerosis patients, Gaia’s Elevida, was ...

STOCKHOLM ― Until their mid to late 30s, some people with multiple sclerosis (MS) can better compensate for damage to their central nervous system, new evidence suggests. Thereafter, at about age 40, ...

JT Lew, PharmD, MBA, managed care pharmacist at MultiCare Health System, spoke to the impacts of processes such as prior authorization and step therapy requirements in the realm of multiple sclerosis ...

A stem cell treatment commonly used for blood cancer appears effective in treating one form of MS The treatment has been available since the 1990s but questions about safety and difficulty have ...

Tiziana Life Sciences Ltd (NASDAQ:TLSA) said new biomarker data from an expanded-access program showed its experimental intranasal therapy reduced brain inflammation and was associated with ...